Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aurora kinase A (AURKA) mRNA is the messenger RNA transcript that encodes the Aurora kinase A protein, a critical serine/threonine kinase involved in the regulation of mitosis [NCBI Gene, 2024]. The protein product is essential for centrosome maturation, spindle assembly, and accurate chromosome segregation during the G2/M transition of the cell cycle [UniProt, 2024]. In many human cancers, AURKA mRNA is significantly overexpressed, which leads to high levels of the kinase that drive oncogenic transformation, genomic instability, and resistance to apoptosis [PubMed, 2023]. Targeting the mRNA transcript itself using RNA-based therapeutics, such as antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs), offers a highly specific strategy to downregulate the AURKA signaling axis at the pre-translational level [Nature Reviews Drug Discovery, 2022]. This approach aims to bypass the limitations of small-molecule inhibitors, such as lack of isoform specificity or the development of acquired resistance in the kinase domain [PubMed, 2022]. By reducing the pool of available mRNA, these therapies can effectively suppress the pro-proliferative and anti-apoptotic functions of Aurora kinase A in various solid tumors and hematological malignancies [PubMed, 2023].
Degradation of the mRNA transcript via RNA interference (RNAi) or RNase H-mediated cleavage, or inhibition of translation through steric hindrance, thereby preventing the synthesis of the Aurora kinase A protein.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aurora kinase A (AURKA) mRNA (AURKA mRNA).